Cyclacel Pharmaceuticals Stock Technical Analysis
| CYCC Stock | USD 1.79 0.04 2.29% |
As of the 23rd of April, Cyclacel Pharmaceuticals shows the risk adjusted performance of (0), and Mean Deviation of 4.37. Cyclacel Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Cyclacel Pharmaceuticals, which can be compared to its peers. Please confirm Cyclacel Pharmaceuticals standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Cyclacel Pharmaceuticals is priced correctly, providing market reflects its regular price of 1.79 per share. Please also double-check Cyclacel Pharmaceuticals jensen alpha, which is currently at (0.16) to validate the company can sustain itself at a future point.
Cyclacel Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cyclacel, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CyclacelCyclacel |
Cyclacel Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 12.25 | Buy | 3 | Odds |
Most Cyclacel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cyclacel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cyclacel Pharmaceuticals, talking to its executives and customers, or listening to Cyclacel conference calls.
Cyclacel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cyclacel Pharmaceuticals Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cyclacel Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cyclacel Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Cyclacel Pharmaceuticals. You can use it to identify possible trend reversals for Cyclacel Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cyclacel Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cyclacel Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cyclacel Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Cyclacel Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 5.42, which is the sum of squared deviations for the predicted Cyclacel Pharmaceuticals price change compared to its average price change.About Cyclacel Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cyclacel Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cyclacel Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cyclacel Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Cyclacel Pharmaceuticals. By analyzing Cyclacel Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cyclacel Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cyclacel Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.0885 | 0.0929 | Price To Sales Ratio | 6.22 | 5.91 |
Cyclacel Pharmaceuticals April 23, 2024 Technical Indicators
Most technical analysis of Cyclacel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cyclacel from various momentum indicators to cycle indicators. When you analyze Cyclacel charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 4.37 | |||
| Coefficient Of Variation | (5,948) | |||
| Standard Deviation | 5.73 | |||
| Variance | 32.84 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 26.49 | |||
| Value At Risk | (8.49) | |||
| Potential Upside | 11.24 | |||
| Skewness | 0.8239 | |||
| Kurtosis | 1.09 |
Cyclacel Pharmaceuticals April 23, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cyclacel stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,607 | ||
| Daily Balance Of Power | 0.24 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 1.77 | ||
| Day Typical Price | 1.77 | ||
| Price Action Indicator | 0.05 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclacel Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Cyclacel Stock refer to our How to Trade Cyclacel Stock guide.Note that the Cyclacel Pharmaceuticals information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Cyclacel Stock analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Cyclacel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuticals. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (26.75) | Revenue Per Share 0.494 | Return On Assets (0.86) | Return On Equity (2.73) |
The market value of Cyclacel Pharmaceuticals is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclacel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.